Jørgensen Niels, Carlsen Elisabeth, Nermoen Ingrid, Punab Margus, Suominen Jyrki, Andersen Anne-Grethe, Andersson Anna-Maria, Haugen Trine B, Horte Antero, Jensen Tina Kold, Magnus Øystein, Petersen Jørgen Holm, Vierula Matti, Toppari Jorma, Skakkebaek Niels E
Department of Growth and Reproduction, Rigshospitalet, The Juliane Marie Centre, Copenhagen, Denmark.
Hum Reprod. 2002 Aug;17(8):2199-208. doi: 10.1093/humrep/17.8.2199.
Denmark and Norway have a three-fold higher incidence of testicular cancer than Estonia and Finland. Groups of young men from Denmark, Norway, Finland and Estonia were investigated to elucidate whether semen parameters and other related parameters follow a gradient between these countries, as does the gradient in incidence of testicular cancer.
In total, 968 young men from the general population in these four countries were investigated according to the same protocol. Possible confounders were evaluated, and included in the statistical analysis when appropriate. Inter-laboratory differences in assessment of sperm concentrations were controlled by an external quality control programme and morphology assessment was centralized to one person.
The Finnish and Estonian men had an adjusted median sperm concentration of 54 and 57 x 10(6)/ml, respectively and the Norwegian and Danish men 41 x 10(6)/ml. The corresponding total sperm counts were 185, 174, 133 and 144 x 10(6). The frequency of normal sperm in men from Finland was 8.9%, Estonia 9.2%, Norway 6.9% and Denmark 6.4%. Within all four groups of men, a relationship between increasing levels of inhibin-B and increasing sperm counts was observed. However, inhibin-B levels were not predictive of sperm count differences between countries.
It is believed that the men examined were representative of the normal population of young men in all four countries as they were recruited from groups attending a compulsory medical examination, and not selected for known fertility or semen quality. Moreover, the majority of participants had no prior knowledge of their fertility potential. It appears that an east-west gradient exists in the Nordic-Baltic area with regard to semen parameters, this being in parallel with the incidences of testicular cancer. Further investigations are required to determine whether these findings are due to genetic differences, to different environments, or perhaps to a combination of both factors.
丹麦和挪威睾丸癌的发病率比爱沙尼亚和芬兰高三倍。对来自丹麦、挪威、芬兰和爱沙尼亚的年轻男性群体进行了调查,以阐明精液参数和其他相关参数是否像睾丸癌发病率那样在这些国家之间呈现梯度变化。
按照相同方案对这四个国家普通人群中的968名年轻男性进行了调查。评估了可能的混杂因素,并在适当情况下纳入统计分析。通过外部质量控制程序控制实验室间精子浓度评估的差异,形态学评估由一人集中进行。
芬兰和爱沙尼亚男性经调整后的精子浓度中位数分别为54和57×10⁶/ml,挪威和丹麦男性为41×10⁶/ml。相应的总精子数分别为185、174、133和144×10⁶。芬兰男性正常精子的频率为8.9%,爱沙尼亚为9.2%,挪威为6.9%,丹麦为6.4%。在所有四组男性中,观察到抑制素B水平升高与精子数增加之间存在关联。然而,抑制素B水平并不能预测各国之间的精子数差异。
据信所检查的男性代表了这四个国家年轻男性的正常人群,因为他们是从参加义务体检的群体中招募的,并非因已知的生育能力或精液质量而被挑选。此外,大多数参与者此前并不知道自己的生育潜力。北欧 - 波罗的海地区在精液参数方面似乎存在东西向梯度,这与睾丸癌的发病率平行。需要进一步调查以确定这些发现是由于基因差异、不同环境,还是可能两者因素共同作用所致。